CR20170010A - MONOCLONAL ANTIBODIES AGAINST HER2 EPITHOPE AND ITS METHODS OF USE - Google Patents
MONOCLONAL ANTIBODIES AGAINST HER2 EPITHOPE AND ITS METHODS OF USEInfo
- Publication number
- CR20170010A CR20170010A CR20170010A CR20170010A CR20170010A CR 20170010 A CR20170010 A CR 20170010A CR 20170010 A CR20170010 A CR 20170010A CR 20170010 A CR20170010 A CR 20170010A CR 20170010 A CR20170010 A CR 20170010A
- Authority
- CR
- Costa Rica
- Prior art keywords
- monoclonal antibodies
- methods
- epithope
- antibodies against
- against her2
- Prior art date
Links
- 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 title abstract 2
- 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 title abstract 2
- 230000003449 preventive effect Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Landscapes
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
La presente invención proporciona anticuerpos monoclonales completamente humanos que reconocen HER2. La invención también proporciona métodos de uso de tales anticuerpos monoclonales en una variedad de indicadores terapéuticos, diagnósticos y preventivos.The present invention provides fully human monoclonal antibodies that recognize HER2. The invention also provides methods of using such monoclonal antibodies in a variety of therapeutic, diagnostic and preventive indicators.
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462013944P | 2014-06-18 | 2014-06-18 | |
| US201462034489P | 2014-08-07 | 2014-08-07 | |
| US201562147960P | 2015-04-15 | 2015-04-15 | |
| US201561149444P | 2015-04-17 | 2015-04-17 | |
| PCT/US2015/036431 WO2015195917A1 (en) | 2014-06-18 | 2015-06-18 | Monoclonal antibodies against her2 epitope and methods of use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CR20170010A true CR20170010A (en) | 2017-04-20 |
Family
ID=59676865
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR20170010A CR20170010A (en) | 2014-06-18 | 2015-06-18 | MONOCLONAL ANTIBODIES AGAINST HER2 EPITHOPE AND ITS METHODS OF USE |
Country Status (1)
| Country | Link |
|---|---|
| CR (1) | CR20170010A (en) |
-
2015
- 2015-06-18 CR CR20170010A patent/CR20170010A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DOP2016000315A (en) | MONOCLONAL ANTIBODIES AGAINST THE HER2 EPITHOPE AND ITS METHODS OF USE | |
| PH12020550781A1 (en) | Anti-jagged1 antibodies and methods of use | |
| PH12016501618A1 (en) | Anti-dll3 antibodies and drug conjugates for use in melanoma | |
| PH12016501894A1 (en) | Anti-ox40 antibodies and methods of use | |
| MY191169A (en) | Anti-fcrh5 antibodies | |
| EA201790545A1 (en) | ANTIBODIES AND IMMUNOCONJUGATES AGAINST HER2 | |
| MX2023005879A (en) | BISPECIFIC ANTIBODIES AGAINST HUMAN CD20 AND THE HUMAN TRANSFERRIN RECEPTOR AND METHODS OF USE. | |
| CO2017004516A2 (en) | Humanized anti-ox40 antibodies | |
| EA201790569A1 (en) | ANTIBODIES AND IMMUNOCONJUGATES AGAINST CLL-1 | |
| PH12017500877B1 (en) | ANTI-CD79b ANTIBODIES AND METHODS OF USE | |
| MX2016015162A (en) | Anti-gpc3 antibodies and immunoconjugates. | |
| MY193661A (en) | Anti-tim3 antibodies and methods of use | |
| MX2015017487A (en) | Humanized or chimeric cd3 antibodies. | |
| MY188940A (en) | Anti-pd-l1 antibodies and diagnostic uses thereof | |
| PH12015501954A1 (en) | Anti-b7-h4 antibodies and immunoconjugates | |
| MX2015012326A (en) | Anti-crth2 antibodies and their use. | |
| MX2023006416A (en) | ANTIBODIES, USES AND METHODS. | |
| MA40535A (en) | Hsp90-targeted inflammation and infection imaging and therapy | |
| CR20170010A (en) | MONOCLONAL ANTIBODIES AGAINST HER2 EPITHOPE AND ITS METHODS OF USE | |
| EA201692560A1 (en) | MONOCLONAL ANTIBODIES AGAINST THE HER2 EPITOPE AND METHODS OF THEIR APPLICATION | |
| AR105316A1 (en) | ANTIBODIES AGAINST THE TRANSFERRINE RECEIVER (ANTI-CD71), ANTI-CD71 ACTIVABLES ANTIBODIES AND THEIR METHODS OF USE | |
| NZ744340A (en) | Anti-jagged1 antibodies and methods of use |